Defining a valid age cutoff in staging of well-differentiated thyroid cancer Journal Article


Authors: Nixon, I. J.; Kuk, D.; Wreesmann, V.; Morris, L.; Palmer, F. L.; Ganly, I.; Patel, S. G.; Singh, B.; Tuttle, R. M.; Shaha, A. R.; Gönen, M.; Shah, J. P.
Article Title: Defining a valid age cutoff in staging of well-differentiated thyroid cancer
Abstract: Background: Age 45 years is used as a cutoff in the staging of well-differentiated thyroid cancer (WDTC) as it represents the median age of most datasets. The aim of this study was to determine a statistically optimized age threshold using a large dataset of patients treated at a comprehensive cancer center. Methods: Overall, 1807 patients with a median follow-up of 109 months were included in the study. Recursive partitioning was used to determine which American Joint Committee on Cancer (AJCC) variables were most predictive of disease-specific death, and whether a different cutoff for age would be found. From the resulting tree, a new age cutoff was picked and patients were restaged using this new cutoff. Results: The 10-year disease-specific survival (DSS) by Union for International Cancer Control (AJCC/UICC) stage was 99.6, 100, 96, and 81 % for stages I–IV, respectively. Using recursive partitioning, the presence of distant metastasis was the most powerful predictor of DSS. For M0 patients, age was the next most powerful predictor, with a cutoff of 56 years. For M1 patients, a cutoff at 54 years was most predictive. Having reviewed the analysis, age 55 years was selected as a more robust age cutoff than 45 years. The 10-year DSS by new stage (using age 55 years as the cutoff) was 99.2, 98, 100, and 74 % for stages I–IV, respectively. Conclusion: A change in age cutoff in the AJCC/UICC staging for WDTC to 55 years would improve the accuracy of the system and appropriately prevent low-risk patients being overstaged and overtreated. © 2015, Society of Surgical Oncology.
Journal Title: Annals of Surgical Oncology
Volume: 23
Issue: 2
ISSN: 1068-9265
Publisher: Springer  
Date Published: 2016-02-01
Start Page: 410
End Page: 415
Language: English
DOI: 10.1245/s10434-015-4762-2
PROVIDER: scopus
PUBMED: 26215199
PMCID: PMC4959904
DOI/URL:
Notes: Article -- Export Date: 3 March 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ashok R Shaha
    698 Shaha
  2. Bhuvanesh Singh
    242 Singh
  3. Snehal G Patel
    412 Patel
  4. Mithat Gonen
    1029 Gonen
  5. Robert M Tuttle
    483 Tuttle
  6. Iain James Nixon
    60 Nixon
  7. Luc Morris
    279 Morris
  8. Ian Ganly
    431 Ganly
  9. Deborah Kuk
    87 Kuk
  10. Jatin P Shah
    722 Shah
  11. Frank Palmer
    82 Palmer